Furthermore, COX6C participates in oncogenic rearrangements, including gene fusions with HMGA2 in uterine leiomyoma and translocations in retroperitoneal lipomas and thyroid carcinomas [28,29]. Here, COX6C is linked to uterine corpus leiomyoma.